Paul Okediji

2PUBLICATIONS
4CO-AUTHORS
EndodonticsBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Mar 15, 2022
Low-dose naltrexone, an opioid-receptor antagonist, is a broad-spectrum analgesic: a retrospective cohort study.

Samuel J Martin, Heath B McAnally, Paul Okediji

|Jul 24, 2020
Cepharanthine: a review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19.

Moshe Rogosnitzky, Paul Okediji, Igor Koman

Pageof 1